Chronicle Journal: Finance

Bristol-Myers - A Strong Buy For Growth Income

Bristol-Myers Squibb Company is a biopharmaceutical company with a mission to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases, asserts Crista Huff, editor of Cabot Undervalued Stocks Advisor.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.